# Caremedi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/caremedi

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: www.caremedi.net
- Total disclosed funding: $28M
- Latest round: Series B (Nov 3, 2023)
- Investors on record: 6

## About

Caremedi is a South Korean company focused on developing and selling wellness devices, including massage equipment that alleviates discomfort and promotes relaxation through targeted therapies.Founded in 2020 and headquartered in Seoul, South Korea, Caremedi specializes in wellness and therapeutic devices. The company has not indicated any significant changes in its business strategy or operations since its inception. Seok-won Lee serves as the CEO, guiding the company's mission in the health and wellness sector.Caremedi specializes in the development and sale of wellness and therapeutic devices, focusing primarily on massage equipment that targets specific body areas to alleviate discomfort and promote relaxation. The company’s core product offerings include foot massagers, calf massagers, and nebulizers, all designed to enhance the user’s well-being by improving circulation and reducing muscle tension. These products serve a diverse clientele, including individuals seeking relief from stress and fatigue, as well as healthcare facilities that incorporate such equipment into their therapeutic practices. Caremedi's products have been made available in various international markets, catering to customers in regions including Asia and parts of Europe, where health and wellness trends are increasingly prioritized.In the most recent year, Caremedi reported revenue of USD 239,762.30. The company engages in a direct-to-consumer sales model, offering its products through online platforms and potentially partnering with retailers to expand its market reach. Caremedi's flagship offerings are designed to appeal to health-conscious individuals and wellness enthusiasts, contributing to the company's growth by delivering quality therapeutic solutions that meet customer demands.

## Funding rounds

- Series B, Nov 3, 2023, $19M — AJU IB Investment, Atinum Investment, Korea Investment Partners, Company K Partners
- Series A, Jan 27, 2022, $8.3M — AJU IB Investment, Atinum Investment, i-SENS
- Seed, Sep 8, 2017, $0.1M — Posco Investment

## Investors

- Posco Investment (https://capitalatlas.ai/funds/posco-investment) — Seed
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series A, Series B
- Atinum Investment (https://capitalatlas.ai/funds/atinum-investment) — Series A, Series B
- i-SENS — Series A
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series B
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series B